Lisanne Tettero

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challenge.

Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challenge.

Journal: NPJ vaccines

Published: May 16, 2024

A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses.

A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses.

Journal: Nature microbiology

Published: April 10, 2024

Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G.

Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G.

Journal: Vaccines

Published: February 16, 2024

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.

Journal: Vaccines

Published: February 10, 2023

Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.

Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.

Journal: NPJ vaccines

Published: September 27, 2022

Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.

Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.

Journal: Vaccine

Published: August 21, 2021

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.

Journal: NPJ vaccines

Published: December 14, 2017

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.

Journal: Frontiers in immunology

Published: August 02, 2016

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.

Journal: Science (New York, N.Y.)

Published: June 04, 2015

Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.

Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: April 15, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026